ALYSSA WILLIAMS: Open Payments
NPI 1477215952 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,200 in 61 payments from 15 companies in 2025. Trend: 2023 $1,029 · 2024 $1,071 · 2025 $1,200
Food & beverage: $1,180Education: $20
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $204 |
| Novartis Pharmaceuticals Corporation | 17 | $199 |
| JAZZ PHARMACEUTICALS INC. | 5 | $157 |
| Lilly USA, LLC | 10 | $132 |
| Alnylam Pharmaceuticals Inc. | 3 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $77 |
| Esperion Therapeutics, Inc. | 4 | $68 |
| GlaxoSmithKline, LLC. | 2 | $57 |
| HARMONY BIOSCIENCES LLC | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $33 |
Products named: SKYRIZI, LEQVIO, XYWAV, ZEPBOUND, ONPATTRO, Kerendia, NEXLETOL, SHINGRIX.
Industry payments across TX — which companies pay providers there.
